Research Output

Filter
Literature review
2013

Indoleamine 2,3-dioxygenase inhibitors: a patent review (2008-2012)

Dolušić, E. & Frédérick, R., 1 Oct 2013, In : Expert opinion on therapeutic targets. 23, 10, p. 1367-1381 15 p.

Research output: Contribution to journalLiterature review

2012

Interuniversity Scientific Computing Facility

Vigneron, J-P., Champagne, B., Deparis, O., Henrard, L., Lambin, P., Vercauteren, D. P., Wautelet, F. & Wouters, J., 2012, In : Nanotechnologies. p. 173-174 2 p.

Research output: Contribution to journalLiterature review

Reversal of Tumoral Immune Resistance by Inhibition of Tryptophan 2,3-Dioxygenase (TDO): Design, Synthesis and Preclinical Evaluation of a Novel TDO Inhibitor.

Dolušić, E., Larrieu, P., Moineaux, L., Stroobant, V., Pilotte, L., Colaux, D., Van den Eynde, B., Masereel, B., Wouters, J. & Frédérick, R., 2012, In : ChemMedChem. p. 371 1 p.

Research output: Contribution to journalLiterature review

2010

Discovery and optimization of indole-pyridinyl-ethanones as novel inhibitors of indoleamine-2-3 dioxygenase (IDO), a promising target for anti-cancer immunotherapy.

Frédérick, R., Blanc, S., Larrieu, P., Moineaux, L., Colette, D., Fraser, G., Stroobant, V., Pilotte, L., Colaux, D., Wouters, J., Masereel, B., Van den Eynde, B. & Dolušić, E., 2010, In : Drugs of the future. 35, suppl A, p. 181-182

Research output: Contribution to journalLiterature review

Inhibition study of monoamine oxidases by ß-carboline derivatives.

Reniers, J., Robert, S., Frédérick, R., Masereel, B., Vincent, S. & Wouters, J., 2010, In : Drugs of the future. 35, suppl A, p. 189

Research output: Contribution to journalLiterature review

Structural and enzymatic study of tryptophan 2,3-dioxgenase (TDO), a potential target in anticancer immunotherapy.

Moineaux, L., Charlier, C., Dolušić, E., Larrieu, P., Pilotte, L., Colaux, D., Stroobant, V., Galleni, M., Masereel, B., Van den Eynde, B., Wouters, J. & Frédérick, R., 2010, In : Drugs of the future. 35, suppl A, p. 189

Research output: Contribution to journalLiterature review

2005

BM-573, a thromboxane A2 modulator, fails to prevent reperfusion injury in acutely ischemic pigs

Kolh, P., Rolin, S., Sato, V., Petein, M., Ghuysen, A., Lambermont, B., Masereel, B., D'Orio, V., Limet, R. & Dogne, JM., 2005, In : Journal of Molecular and Cellular Cardiology . 39, p. 1035 1 p.

Research output: Contribution to journalLiterature review

2004

Characterization of preferential activity on platelet thromboxane A2 receptors of BM-613, a new thromboxane A2 antagonist

Hanson, J., Rolin, S., De Leval, X., Neven, P., Masereel, B., Pirotte, B. & Dogné, J-M., 2004, In : Fundamental and Clinical Pharmacology.

Research output: Contribution to journalLiterature review

In vivo pharmacological evaluation of BM-573, an original thromboxane A2 receptor antagonist and thromboxane synthase inhibitor.

Hanson, J., Kolh, P., Rolin, S., Tchana-Sato, V., De Leval, X., Petein, M., Masereel, B., Pirotte, B., Dogné, J-M. & Lambermont, B., 2004, In : Fundamental and Clinical Pharmacology.

Research output: Contribution to journalLiterature review

2003

A dual thromboxane inhibitor and thromboxane receptor antagonist prevents pig myocardial infarction induced by coronary thrombosis

Rolin, S., Petein, M., Tchana-Sato, V., Dogné, J-M., Lambermont, B., Ghuysen, A., Kolh, P. & Masereel, B., 2003, In : European Heart Journal. 24, Suppl. S

Research output: Contribution to journalLiterature review

2000

BM-144, a novel thromboxane A2 receptor antagonist relaxes trachea guinea pig in vitro

de Leval, X., Delarge, J., Rolin, S., Masereel, B. & Dogne, J-M., 2000, In : Journal of Allergy and Clinical Immunology. 105, 1, p. S21

Research output: Contribution to journalLiterature review

Profile of nimesulide and nimesulide beta-cyclodextrin on chondrocyte metabolism.

De Leval, X., Dogne, J-M., Masereel, B., Pirotte, B., Reginster, J-Y., Neven, P., Labasse, A., Delarge, J. & Henrotin, Y., 2000, In : Fundamental and Clinical Pharmacology. 14, p. 169

Research output: Contribution to journalLiterature review

1998

Design, synthesis and pharmacology of sulfonylcyanoguanidines and sulfonamidonitroethylenes as bioisosteres of hypoglycemic sulfonylureas

Masereel, B., Ouedraogo, R., Dogne, J-M., Antoine, M-H., De Tullio, P., Pirotte, B., Pochet, L., Delarge, J. & Lebrun, P., 1998, In : Journal de Pharmacie de Belgique. 53

Research output: Contribution to journalLiterature review

Design of new potential hypoglycemic drugs

Masereel, B., De Tullio, P., Dogne, J-M., Lacan, F., Pirotte, B., Pochet, L., Somers, F. & Delarge, J., 1998, In : Journal de Pharmacie de Belgique. 53

Research output: Contribution to journalLiterature review

1997

Substitution of 2-carbonyl in phenytoin ans its consequences on the pharmacological efficacy and pharmacokinetics

Lambert, D. M., Masereel, B., Gallez, B., Geurts, M., Poupaert, J. & Scriba, G. K. E., 1997, In : J. Pharm. Belg.. 52, (2b), p. 32

Research output: Contribution to journalLiterature review

1996

BM 34, an anticonvulsivant sulfonylurea with a phenytoin-like profile

Masereel, B., Lambert, D. M., Dogne, J-M., de Tullio, P., Pirotte, B., Pochet, L. & Delarge, J., 1996, In : J. Pharm. Belg.. 51, (1), p. 115

Research output: Contribution to journalLiterature review